HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
IL10RB
interleukin 10 receptor subunit beta
Chromosome 21 Β· 21q22.11
NCBI Gene: 3588Ensembl: ENSG00000243646.11HGNC: HGNC:5965UniProt: A0A1B0GTI5
106PubMed Papers
21Diseases
3Drugs
19Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneReceptor
CLINICAL
Clinical TrialsOMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
coreceptor activityprotein bindinginterleukin-10-mediated signaling pathwaypositive regulation of cellular respirationinflammatory bowel disease 25Autosomal recessive early-onset inflammatory bowel diseaseCOVID-19IL10-related early-onset inflammatory bowel disease
✦AI Summary

IL10RB encodes a shared cell surface receptor subunit required for signaling by multiple class 2 cytokines including IL-10, IL-22, IL-26, IL-28, and type III interferons 1. The protein functions as a co-receptor that activates JAK-STAT signaling pathways upon ligand binding, leading to expression of interferon-stimulated genes and antiviral responses. In intestinal biology, IL10RB is essential for IL-22-mediated Paneth cell formation and antimicrobial peptide expression, with IBD-associated loss-of-function mutations abolishing Paneth cell development 1. The receptor plays critical roles in immune regulation, as IL10RB signaling maintains functional PD-1int TCF-1+ CD8+ T cells and prevents T cell exhaustion in cancer models 2. Clinically, IL10RB variants are associated with severe COVID-19 susceptibility, likely through impaired interferon signaling 3, and autoimmune conditions including systemic lupus erythematosus 4. Biallelic loss-of-function mutations cause infant-onset inflammatory bowel disease (IBD25), demonstrating the gene's essential role in maintaining intestinal immune homeostasis 5. The gene's expression is regulated by transcription factors Sp8 and Sp9, and is elevated in Alzheimer's disease brains 6.

Sources cited
1
IL10RB is required for IL-22 signaling and Paneth cell formation; IBD-associated mutations abolish Paneth cells
PMID: 36002022
2
IL10RB signaling maintains functional CD8+ T cells and prevents T cell exhaustion
PMID: 34879221
3
IL10RB variants associated with critical COVID-19 susceptibility through interferon signaling
PMID: 35255492
4
IL10RB polymorphisms associated with systemic lupus erythematosus susceptibility
PMID: 37511050
5
Biallelic IL10RB mutations cause infant-onset inflammatory bowel disease
PMID: 38281300
6
IL10RB expression regulated by Sp8 and Sp9 transcription factors; elevated in Alzheimer's disease
PMID: 35811529
Disease Associationsβ“˜21
inflammatory bowel disease 25Open Targets
0.73Strong
Autosomal recessive early-onset inflammatory bowel diseaseOpen Targets
0.70Moderate
COVID-19Open Targets
0.58Moderate
IL10-related early-onset inflammatory bowel diseaseOpen Targets
0.55Moderate
inflammatory bowel diseaseOpen Targets
0.42Moderate
hepatitis C virus infectionOpen Targets
0.38Weak
ulcerative colitisOpen Targets
0.38Weak
chronic hepatitis C virus infectionOpen Targets
0.28Weak
hepatitis D virus infectionOpen Targets
0.28Weak
pancreatic ductal adenocarcinomaOpen Targets
0.26Weak
acute myeloid leukemia by FAB classificationOpen Targets
0.26Weak
Malignant Pancreatic NeoplasmOpen Targets
0.26Weak
pancreatic carcinomaOpen Targets
0.26Weak
pancreatic neoplasmOpen Targets
0.26Weak
major depressive disorderOpen Targets
0.25Weak
obesityOpen Targets
0.24Weak
osteoarthritisOpen Targets
0.21Weak
respiratory failureOpen Targets
0.20Weak
genetic disorderOpen Targets
0.19Weak
systemic lupus erythematosusOpen Targets
0.17Weak
Inflammatory bowel disease 25, autosomal recessiveUniProt
Pathogenic Variants19
NM_000628.5(IL10RB):c.173+2T>GPathogenic
Inflammatory bowel disease 25
β˜…β˜…β˜†β˜†2024
NM_000628.5(IL10RB):c.611G>A (p.Trp204Ter)Pathogenic
Inflammatory bowel disease 25
β˜…β˜…β˜†β˜†2023β†’ Residue 204
NM_000628.5(IL10RB):c.689C>A (p.Ser230Ter)Pathogenic
Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†2025β†’ Residue 230
NM_000628.5(IL10RB):c.331+1G>ALikely pathogenic
Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†2025
NM_000628.5(IL10RB):c.168C>G (p.Tyr56Ter)Pathogenic
Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†2025β†’ Residue 56
NM_000628.5(IL10RB):c.50-2A>TPathogenic
not provided
β˜…β˜†β˜†β˜†2024
NM_000628.5(IL10RB):c.804+2delLikely pathogenic
Susceptibility to severe COVID-19
β˜…β˜†β˜†β˜†2024
NM_000628.5(IL10RB):c.805-2A>CLikely pathogenic
Hepatitis B virus, susceptibility to;Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†2024
NM_000628.5(IL10RB):c.174-1G>ALikely pathogenic
Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†2023
NM_000628.5(IL10RB):c.49+2T>GLikely pathogenic
Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†2020
NM_000628.5(IL10RB):c.331+1G>CLikely pathogenic
Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†2019
NM_000628.5(IL10RB):c.120G>A (p.Trp40Ter)Pathogenic
Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†2019β†’ Residue 40
NM_000628.5(IL10RB):c.477G>A (p.Trp159Ter)Pathogenic
Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†2019β†’ Residue 159
NM_000628.5(IL10RB):c.476G>A (p.Trp159Ter)Pathogenic
Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†2019β†’ Residue 159
NM_000628.5(IL10RB):c.53del (p.Leu18fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2018β†’ Residue 18
NM_000628.5(IL10RB):c.574C>T (p.Arg192Ter)Pathogenic
Inflammatory bowel disease 25
β˜…β˜†β˜†β˜†β†’ Residue 192
NM_000628.5(IL10RB):c.300G>A (p.Trp100Ter)Pathogenic
Inflammatory bowel disease 25
β˜†β˜†β˜†β˜†2023β†’ Residue 100
NM_000628.5(IL10RB):c.25_43del (p.Leu9fs)Likely pathogenic
Inflammatory bowel disease 25
β˜†β˜†β˜†β˜†2023β†’ Residue 9
NM_000628.5(IL10RB):c.421G>T (p.Glu141Ter)Pathogenic
Inflammatory bowel disease 25
β˜†β˜†β˜†β˜†2011β†’ Residue 141
View on ClinVar β†—
Drug Targets3
EFLEPEDOCOKIN ALFAPhase II
IL22 Receptor agonist
graft versus host disease
PEGILODECAKINPhase III
IL-10 receptor agonist
pancreatic neoplasm
PEGINTERFERON LAMBDA-1APhase III
Interferon lambda receptor agonist
acute myeloid leukemia by FAB classification
Related Genes
CTSSProtein interaction100%CSF2Protein interaction100%JAK2Protein interaction99%IL6Protein interaction99%IL2Protein interaction96%IFNL3Protein interaction93%
Tissue Expression6 tissues
Lung
100%
Liver
74%
Ovary
51%
Brain
33%
Bone Marrow
4%
Heart
4%
Gene Interaction Network
Click a node to explore
IL10RBCTSSCSF2JAK2IL6IL2IFNL3
PROTEIN STRUCTURE
Preparing viewer…
PDB3LQM Β· 2.14 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.05LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.78 [0.58–1.05]
RankingsWhere IL10RB stands among ~20K protein-coding genes
  • #4,483of 20,598
    Most Researched106 Β· top quartile
  • #2,233of 5,498
    Most Pathogenic Variants19
  • #10,549of 17,882
    Most Constrained (LOEUF)1.05
Genes detectedIL10RB
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation.
PMID: 36002022
Cell Stem Cell Β· 2022
1.00
2
Interleukin-10 receptor signaling promotes the maintenance of a PD-1
PMID: 34879221
Immunity Β· 2021
0.90
3
Whole-genome sequencing reveals host factors underlying critical COVID-19.
PMID: 35255492
Nature Β· 2022
0.80
4
Urinary proteomics identifies distinct immunological profiles of sepsis associated AKI sub-phenotypes.
PMID: 39695715
Crit Care Β· 2024
0.70
5
Association of
PMID: 37511050
Int J Mol Sci Β· 2023
0.60